HRG launches ranking system for top prescriptions by ZIP code
WAUKESHA, Wis. — Hamacher Resource Group is offering pharmacists a new service that it said would allow them to get the top prescriptions dispensed in their two-digit ZIP code to ensure they are accurately and competitively pricing drugs.
HRG said the service, Rx Top Sellers, would provide data on the top 200, 500, 750 or 1,000 prescriptions and include cash median prices that are charged by food-drug retailers and independent pharmacies, as well as mass merchandise retailers.
The pricing intelligence is based on industry data, which HRG uses to develop a dispensing rank and segments by ZIP code and outlet type. The data are updated bi-monthly and delivered on an ad-hoc basis in a Microsoft Excel spreadsheet.
"We have several options for pharmacists when it comes to making sure their prescription pricing is where they want it to be competitively in their area," HRG co-owner and director of operations Julie Bonnell said. "Rx Top Sellers fills a niche in that it is a one-type purchase for pharmacists who want to ensure they aren’t under- or over-pricing their prescription drug cash transactions. The report is available without a prescription, which is a good fit for some community pharmacies who want to audit their current pricing strategy."
Hy-Vee to merge Iowa drug store, supermarket
CHEROKEE, Iowa — The Hy-Vee Drugstore in Cherokee, Iowa, will merge with the company’s supermarket in the town next month, the supermarket pharmacy chain said Wednesday.
"Having all our pharmacists together at the same location creates a more efficient operation and enables us to add Sunday hours, a service customers have requested," Hy-Vee assistant VP operations for the company’s northwest district Tim Stupka said.
All of the drug store’s employees will be transferred to the supermarket or to the company’s clinic pharmacy in Marcus, Iowa, effective April 29.
Teva appoints former Dyax executive
JERUSALEM — Teva Pharmaceutical Industries has appointed a former executive from Dyax to its executive team, the Israeli generic drug maker said.
Teva announced the appointment of Ivana Magovčević-Liebisch as SVP and head of corporate business development, effective April 1. Magovčević-Liebisch served as EVP and COO for Dyax, a Burlington, Mass.-based drug company.
"Teva continues to build its premier leadership team, and we anticipate that Ivana, with her track record in partnering and licensing agreements and her extensive industry experience from R&D to commercial operations, will play an important role in the ongoing success of our business development programs," Teva group EVP human resources and chief integration officer Ika Abravanel said.